Germany Mice Model Market (2025-2030)
The Germany Mice Model Market was valued at $81.6 Million in 2025 and projected to reach to $132.2 Million by 2030, representing a compound annual growth rate of 10.1%. Germany's mice model market is poised for sustained expansion through 2030, driven by the country's leadership in pharmaceutical innovation and biotechnology research.
Germany Mice Model Market Trends and Insights
- Germany maintains a strong position in the European research landscape, driven by its world-class pharmaceutical and biotechnology sectors that rely heavily on preclinical testing models.
- The country's investment in life sciences research and stringent regulatory frameworks supporting animal model utilization continue to fuel demand for mice models across academic institutions, contract research organizations, and pharmaceutical companies. The 10.1% compound annual growth rate (CAGR) reflects Germany's commitment to advancing drug discovery and development processes.
- Germany's robust healthcare infrastructure and leading research institutions position the country as a critical hub for mice model procurement and utilization.
- Between 2025 and 2030, Germany is expected to see increased adoption of specialized mouse strains and genetically modified models, supporting the country's competitive advantage in personalized medicine and translational research initiatives..
Key Market Statistics
- CAGR (2025-2030) 10.1% CAGR
- Market Size, 2025 ~USD 81.6 Million
- Forecast, 2030 ~USD 132.2 Million
- Country Germany
Germany Mice Model Market Overview
Market Valuation Growth :
Germany's mice model market is valued at $81.6 million in 2025, with a projected CAGR of 10.1% through 2030, reaching $132.2 million. This growth trajectory reflects strong demand from the country's robust pharmaceutical and biotechnology sectors.
European Research Leadership :
Germany maintains a dominant position in European preclinical research, supported by world-class research institutions, universities, and biotech companies that depend on advanced mice models for drug development and safety testing.
Regulatory Compliance Driver :
Stringent German and EU regulatory frameworks mandate comprehensive preclinical testing using mice models, creating sustained demand from pharmaceutical companies seeking to meet compliance requirements for drug approval and market entry.
Life Sciences Investment :
Germany's significant government and private sector investment in life sciences research, particularly in oncology, neurology, and immunology, drives continuous demand for specialized and genetically modified mice models for translational research.
Germany Mice Model Market Dynamics
- The market benefits from strong institutional support, including funding from the German Research Foundation (DFG) and the Federal Ministry of Education and Research, which prioritize preclinical research infrastructure.
- Increasing adoption of personalized medicine and gene therapy development further accelerates demand for specialized mouse models. The regulatory environment in Germany and the EU continues to emphasize the importance of preclinical animal models in drug development pipelines.
- With major pharmaceutical hubs concentrated in regions like Hesse and Baden-Württemberg, coupled with growing biotech startups, the market is expected to maintain double-digit growth.
- Investment in advanced breeding facilities and genetically engineered mouse models will remain critical to meeting evolving research demands..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Germany's mice model market will grow from $81.6M (2025) to $132.2M (2030), representing a 10.1% CAGR.
- Germany's pharmaceutical and biotechnology sectors drive significant demand for preclinical mice models in drug discovery.
- Germany's regulatory environment and research infrastructure position it as a leading European hub for mice model utilization.
- Specialized and genetically modified mouse strains are expected to drive market expansion in Germany through 2030.
Mice Model Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Model Type & Service) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 10% from 2025 to 2030 |
| Largest Segment | MODEL TYPE (Model Type & Service) |
| Market Size Base Year (Billions) | ~USD 1.7 (2025) |
| Revenue Forecast (Billions) | ~USD 2.74 (2030) |
| Segments Covered | Model Type & Service, Type, Technology, Application, Therapeutic Area |
Germany Mice Model Market Report Segmentation
5 segment dimensions are covered across the global market.
By Model Type & Service
- Model Type
- Services
By Type
- Breeding Services
- Cryopreservation Services
- Genetically Engineered Mice
- Hybrid/Congenic Mice
- Inbred Mice
- Other Services
- Outbred Mice
- Quarantine Services
- Rederivation Services
By Technology
- Crispr/Cas9
- Embryonic Stem Cell Injections
- Microinjections
- Nuclear Transfer Technique
- Other Technologies
By Application
- Drug Discovery & Development
- Personalized Medicine
- Research Applications
By Therapeutic Area
- Cardiovascular Diseases
- Immunology
- Metabolic Diseases
- Neurology
- Oncology
- Other Therapeutic Areas
Target Audience
- Pharmaceutical Companies : German and international pharma firms need detailed market data to optimize preclinical testing strategies, allocate R&D budgets, and understand regulatory requirements specific to the German market for drug development.
- Biotechnology Firms : Biotech companies operating in Germany require market insights to identify growth opportunities, benchmark against competitors, and understand demand trends for specialized mice models in emerging therapeutic areas.
- Contract Research Organizations (CROs) : CROs serving German pharmaceutical and biotech clients need market-specific data to develop service offerings, pricing strategies, and capacity planning aligned with Germany's preclinical research demands.
- Research Institutions & Universities : German research centers and academic institutions require market intelligence to secure funding, justify infrastructure investments, and understand industry collaboration opportunities in the mice model sector.
- Investors & Venture Capital : Investment firms targeting the German life sciences sector need comprehensive market data to evaluate opportunities, assess growth potential, and make informed decisions on funding biotech and research-focused ventures.
Key Companies in the Germany Mice Model Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HORIZON DISCOVERY GROUP PLC | United Kingdom | Private Company | Screening,Research Reagents,Diagnostics, |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | United States | Public Company | Routine and wellness diagnostics (chemistry, hematology, urinalysis, wellness programs),Specialty and esoteric testing (gene-based, oncology, infectious disease, women’s health, pharmacogenetics),Biopharma Laboratory Services (clinical trial, central lab, medical device and diagnostic R&D), |
| CHARLES RIVER LABORATORIES | United States | Public Company | Discovery and Safety Assessment,Research Models and Services,Manufacturing Solutions, |
| THE JACKSON LABORATORY | United States | Foundation/Charitable Institution | Mouse breeding and colony management services,Cryopreservation, recovery, and genetic resource management,Phenotyping, efficacy testing, and study-ready induced models, |
| INOTIV | United States | Public Company | Research Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software, |
| JSR CORPORATION | Japan | Private Company | Digital Solutions (lithography, photoresists, packaging, CMP, display materials),Plastics (synthetic resins: ABS, AES, AS, ASA),Life Sciences (diagnostic reagents, bioprocess materials, drug discovery support), |
| BIOCYTOGEN | China | Public Company | Gene-Editing Services,Pharmacological Efficacy & Toxicology Services,Model Animals (Breeding & Sales), |
| SHANGHAI MODEL ORGANISMS CENTER, INC. | China | Public Company | Standard and disease mouse models (including toolbox and disease-specific strains),Customized genetically engineered models (KO, KI, humanized, transgenic),Preclinical services (non-GLP tox, PK, pharmacology/PD, phenotype analysis), |
| TRANS GENIC INC. | Japan | Public Company | Drug Discovery Support (non-clinical, bioequivalence, safety tests),Transgenic Models & Reagents (GM mice, antibodies, proteins, cells),Glycan Synthesis & Sugar Chain Analysis, |
| HARBOUR BIOMED | China | Public Company | Harbour Mice platform licensing and collaborations,Immunology clinical assets (e.g., batoclimab, HBM7020, HBM9378),Oncology clinical assets (e.g., porustobart, solid tumor portfolio), |
| GENOWAY | France | Public Company | Custom KO/KI mouse models,Custom KO/KI rat models,Humanized and immunodeficient rodent models (catalog and custom), |
| GEMPHARMATECH | China | Public Company | Standard GEMM catalog (knockout, conditional, knock-in, point-mutation, transgenic),Custom model generation and tool mice,Preclinical testing services, |
| VIVO BIO TECH LTD. | India | Public Company | In vivo and in vitro toxicity, PK/TK, and pharmacology services,SPF lab animals, rodent breeding, custom models, and lab diets,Genotoxicity screening and analytical services, |
HORIZON DISCOVERY GROUP PLC
Horizon Discovery Group PLC is a United Kingdom-based private company founded in 2005 with 428 employees. The company operates in the life sciences sector, providing specialized research and development services.
LABORATORY CORPORATION OF AMERICA HOLDINGS
Laboratory Corporation of America Holdings is a major United States public company founded in 1995 with 66,385 employees. It is a leading provider of clinical laboratory services and drug development support.
CHARLES RIVER LABORATORIES
Charles River Laboratories is a United States public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services, research models, and safety assessment services.
THE JACKSON LABORATORY
The Jackson Laboratory is a United States foundation and charitable institution founded in 1929 with 2,100 employees. It is a premier research institution specializing in mammalian genetics and genomics.
INOTIV
Inotiv is a United States public company founded in 1974 with 1,996 employees. The company provides research models, services, and products for the pharmaceutical and biotechnology industries.
JSR CORPORATION
JSR Corporation is a Japan-based private company founded in 1948 with 7,997 employees. The company operates in advanced materials and life sciences sectors.
BIOCYTOGEN
Biocytogen is a China-based public company founded in 2008 with 1,443 employees. The company specializes in the development of genetically engineered animal models for research and drug development.
SHANGHAI MODEL ORGANISMS CENTER, INC.
Shanghai Model Organisms Center, Inc. is a China-based public company founded in 2000 with 848 employees. The company provides model organism services and products for biomedical research.
TRANS GENIC INC.
Trans Genic Inc. is a Japan-based public company founded in 1998 with 227 employees. The company develops and provides transgenic animal models for research applications.
HARBOUR BIOMED
Harbour Biomed is a China-based public company founded in 2016 with 272 employees. The company focuses on antibody and immunotherapy research and development.
GENOWAY
Genoway is a France-based public company founded in 1999 with 157 employees. The company specializes in the generation of genetically modified animal models for research.
GEMPHARMATECH
GemPharmatech is a China-based public company founded in 2017 with 1,590 employees. The company provides laboratory animal models and related research services.
VIVO BIO TECH LTD.
Vivo Bio Tech Ltd. is an India-based public company founded in 1987 with 174 employees. The company provides contract research services and laboratory animal models for pharmaceutical and biotechnology research.
Reasons to Buy this Report
- Market-Specific Sizing & Forecasts : Access precise valuation data for Germany's mice model market with country-specific CAGR (10.1%) and detailed projections through 2030, enabling accurate budget allocation and investment planning for German market operations.
- Regulatory & Compliance Insights : Understand Germany's unique regulatory landscape, including EU directives and national requirements that drive demand for mice models, helping companies align product offerings with stringent compliance standards.
- Competitive Landscape Analysis : Identify key players, research institutions, and pharmaceutical companies operating in Germany's mice model ecosystem, enabling strategic partnerships and market entry strategies tailored to the German market.
- Growth Driver Identification : Discover sector-specific growth catalysts in Germany including personalized medicine adoption, gene therapy development, and government research funding initiatives that create targeted business opportunities.
- Strategic Decision Support : Leverage Germany-focused market intelligence to support expansion decisions, product development priorities, and resource allocation for companies targeting the German and broader European preclinical research market.
Frequently asked questions
What is the current size of Germany's mice model market?
Germany's mice model market is valued at $81.6 million in 2025 and is projected to reach $132.2 million by 2030.
What is the growth rate of Germany's mice model market?
Germany's mice model market is growing at a compound annual growth rate (CAGR) of 10.1% from 2025 to 2030.
Which sectors drive demand for mice models in Germany?
Germany's pharmaceutical, biotechnology, and academic research sectors are the primary drivers of mice model demand for preclinical drug testing and development.
What types of mice models are most in demand in Germany?
Germany shows increasing demand for specialized mouse strains and genetically modified models that support personalized medicine and translational research.
Why is Germany a significant market for mice models?
Germany's world-class research institutions, robust pharmaceutical sector, stringent regulatory standards, and investment in life sciences research make it a critical hub for mice model procurement and utilization.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include the International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), European Molecular Biology Laboratory−European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association (SGV), Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association (AMMRA), Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food and Drug Administration (US FDA), Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the total size of the mice model market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
An animal model is a valuable resource in biomedical research, chosen for its ability to replicate certain aspects of biological processes or diseases observed in humans. A mouse model is a genetically engineered or naturally occurring mouse strain used in biomedical research to mimic human diseases or conditions. These models are valuable for their biological similarity to humans, ability to be genetically manipulated, and cost-effectiveness, enabling researchers to study disease mechanisms and test novel drug therapies efficiently. Mice share over 95% of human DNA and are biologically similar to humans, thereby being susceptible to similar diseases due to the genetic build-up.
Stakeholders
- Manufacturers & Distributors of Mice Models
- CROs & CDMOs
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Market Research & Consulting Firms
- Researchers & Scientists
- Regulatory Authorities & Institutes
Report Objectives
- To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, product end user, service end user, and region
- To provide detailed information regarding the leading factors driving the growth of the market (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall mice models market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- Track & analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the mice models market.
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the mice model market.
Get the Full Mice Model Market Report
Full forecast, segment splits, and company analysis for all Mice Model Market.
- US Mice Model Market
- Canada Mice Model Market
- UK Mice Model Market
- France Mice Model Market
- Italy Mice Model Market
- Spain Mice Model Market
- China Mice Model Market
- Japan Mice Model Market
- India Mice Model Market
- Australia Mice Model Market
- South Korea Mice Model Market
- Brazil Mice Model Market
- Mexico Mice Model Market
- United Arab Emirates Mice Model Market
- Rest Of Europe Mice Model Market
- Rest Of The Asia Pacific Mice Model Market
- Rest Of Asia Pacific Mice Model Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report